Tags

Type your tag names separated by a space and hit enter

[CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice].
Praxis (Bern 1994). 2021; 110(3):141-142.P

Abstract

CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice Abstract. The COVID-19 pandemic represents a major public health problem. A fraction of the population is at increased risk of developing complications of this disease, in particular older subjects as well as diabetic, obese and hypertensive patients. With regard to patients with high blood pressure, the existence of an increased risk remains to be confirmed in large controlled trials. So far the findings regarding this question are reassuring, whether these patients are treated or not. There seems to be no reason to worry when using blockers of the renin-angiotensin system. The observations available to date suggest that COVID-19 vaccine can be administered safely to hypertensive patients. In conclusion, there is no reason to implement changes in the care of hypertensive patients due to the pandemic.

Authors+Show Affiliations

Service de Néphrologie et Hypertension, CHUV, Lausanne.Faculté de biologie et de médecine, Université de Lausanne.

Pub Type(s)

Journal Article

Language

ger

PubMed ID

33653105

Citation

Wuerzner, Grégoire, and Bernard Waeber. "[CME/Answers: Hypertension and the COVID-19 Pandemic: what to Consider in Medical Practice]." Praxis, vol. 110, no. 3, 2021, pp. 141-142.
Wuerzner G, Waeber B. [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. Praxis (Bern 1994). 2021;110(3):141-142.
Wuerzner, G., & Waeber, B. (2021). [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. Praxis, 110(3), 141-142. https://doi.org/10.1024/1661-8157/a003636
Wuerzner G, Waeber B. [CME/Answers: Hypertension and the COVID-19 Pandemic: what to Consider in Medical Practice]. Praxis (Bern 1994). 2021;110(3):141-142. PubMed PMID: 33653105.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice]. AU - Wuerzner,Grégoire, AU - Waeber,Bernard, PY - 2021/3/3/entrez PY - 2021/3/4/pubmed PY - 2021/3/5/medline KW - Blocker des Renin-Angiotensin-Systems KW - Bluthochdruck KW - COVID-19 KW - COVID-19 vaccine KW - Hypertonie KW - Risikofaktoren KW - antihypertensive Therapie KW - antihypertensive therapy KW - blockers of the renin-angiotensin system KW - bloqueurs du système rénine-angiotensine KW - facteurs de risque KW - hypertension KW - hypertension artérielle KW - risk factors KW - traitement antihypertenseur KW - vaccination Covid-19 SP - 141 EP - 142 JF - Praxis JO - Praxis (Bern 1994) VL - 110 IS - 3 N2 - CME/Answers: Hypertension and the COVID-19 Pandemic: What to Consider in Medical Practice Abstract. The COVID-19 pandemic represents a major public health problem. A fraction of the population is at increased risk of developing complications of this disease, in particular older subjects as well as diabetic, obese and hypertensive patients. With regard to patients with high blood pressure, the existence of an increased risk remains to be confirmed in large controlled trials. So far the findings regarding this question are reassuring, whether these patients are treated or not. There seems to be no reason to worry when using blockers of the renin-angiotensin system. The observations available to date suggest that COVID-19 vaccine can be administered safely to hypertensive patients. In conclusion, there is no reason to implement changes in the care of hypertensive patients due to the pandemic. SN - 1661-8157 UR - https://www.unboundmedicine.com/medline/citation/33653105/[CME/Answers:_Hypertension_and_the_COVID-19_Pandemic:_What_to_Consider_in_Medical_Practice]. L2 - https://econtent.hogrefe.com/doi/10.1024/1661-8157/a003636?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -